Anomaly Detection in the Artificial Pancreas



Similar documents
A Fuzzy Controller for Blood Glucose-Insulin System

Title: Using Formal Methods to Improve Safety of Home-Use Medical Devices

Medical Policy Insulin Pumps

Insulin dosage based on risk index of Postprandial Hypo- and Hyperglycemia in Type 1 Diabetes Mellitus with uncertain parameters and food intake

[Frida Svendsen and Jennifer Southern] University of Oxford. October 2014

Imagine a world... Believe in better control. MiniMed Veo Paradigm System Questions and Answers About Insulin Pumping

Universita degli Studi di Padova Facolta di Ingegneria

Insulin Infusion Pumps

JDRF Type One Nation Research Summit Diabetes Technology: A Bridge to a Cure

X-Plain Hypoglycemia Reference Summary

Imagine a world... Believe in better control. MiniMed Veo Paradigm System

Algorithms for Glycemic Management of Type 2 Diabetes

Department Of Biochemistry. Subject: Diabetes Mellitus. Supervisor: Dr.Hazim Allawi & Dr.Omar Akram Prepared by : Shahad Ismael. 2 nd stage.

An Improved PID Switching Control Strategy for Type 1 Diabetes

Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control. Linda Macdonald, M.D. November 19, 2008

INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco

Insulin Pump Therapy and Continuous Glucose Sensor Use in the Management of Diabetes Mellitus

Alternative method for delivering insulin using continuous subcutaneous insulin infusion (CSII) open loop system

Department of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA

WHY THE IMPLANTABLE INSULIN PUMP WORKS SO WELL

Supplementary appendix

Managing Diabetes in the School Setting. Alabama State Department of Education Alabama Board of Nursing

Taking Insulin Pumps to School. Rachel Calendo, MS, RN, CPNP, CDE, Martha Cuevas, RN, BSN, CPT

ARTICLE IN PRESS Biomedical Signal Processing and Control xxx (2012) xxx xxx

4/7/2015 CONFLICT OF INTEREST DISCLOSURE OBJECTIVES. Conflicts of Interest None Heather Rush. Heather M. Rush, APRN, CDE Louisville, KY

Overview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health

Diabetes Medications: Insulin Therapy

Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner

Objectives PERINATAL INSULIN PUMPS: BASICS FOR NURSES. Historical Perspective. Insulin Pumps in Pregnancy. Insulin Pumps in the US

Nutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT

Section 5: Type 2 Diabetes

Automatic Blood Glucose Control in Diabetes

A guidebook for people with diabetes

Inpatient Treatment of Diabetes

Implications of Meal Library & Meal Detection to Glycemic Control of Type 1 Diabetes Mellitus through MPC Control

TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU

Diabetes mellitus. Lecture Outline

AN INTELLIGENT SUPPORT SYSTEM FOR DIABETIC PATIENTS

Methods for Delivering Insulin and Monitoring Blood Sugar. A Review of the Research for Children, Teens, and Adults With Diabetes

Baskets of Care Diabetes Subcommittee

Textbook: Chapter 12 pages , Chapter 13 pages

INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL

Get Primed on Pumps: A beginners guide to Insulin Pump Therapy

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus

Teledermatology: an experience in Tucumán

Insulin Delivery Options: Inhale, Inject, and Infuse. Traci Evans, A.N.P., B.C.-A.D.M. Nurse Practitioner The Diabetes Center Ocean Springs, MS

Cardiovascular Disease Risk Factors Part XII Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner September 15, 2005

Pattern Recognition in Medical Images using Neural Networks. 1. Pattern Recognition and Neural Networks

Basal and Bolus Insulin 7/16/2014. Jackie Aday RN, BSN, CDE Jeni Neighbors RN, BSN, CDE. BASAL: Small amount of insulin infused every few minutes

Medical Coverage Policy Glucose Monitoring Systems sad

Criteria: CWQI HCS-123 (This criteria is consistent with CMS guidelines for External Infusion Insulin Pumps)

MEDICAL COVERAGE POLICY. SERVICE: Insulin Pump and Continuous Glucose Monitoring. PRIOR AUTHORIZATION: Required. POLICY:

Insulin Pump Therapy. Jen Block, MSN, RN, CDE Stanford University Department of Pediatric Endocrinology

BASAL BOLUS INSULIN FOR MEDICAL- SURGICAL INPATIENTS

Clinical Validity of Insulin Bolus Calculators

The What, Why, Who & How of Insulin Pumps. Bridget Lydon May 2014

Tuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University

HOW TO CARE FOR A PATIENT WITH DIABETES

1333 Plaza Blvd, Suite E, Central Point, OR *

SARASOTA MEMORIAL HOSPITAL

GESTATIONAL DIABETES. Diabete Gestazionale (Lingua Inglese)

External Insulin Pumps Corporate Medical Policy

Glucose-Insulin System based on Minimal Model: a Realistic Approach

NCT sanofi-aventis HOE901_3507. insulin glargine

2. What Should Advocates Know About Diabetes? O

glucose and fatty acids to raise your blood sugar levels.

US Diabetic Devices Industry Research Report: KenResearch

tips Insulin Pump Users 1 Early detection of insulin deprivation in continuous subcutaneous 2 Population Study of Pediatric Ketoacidosis in Sweden:

Gayle Curto, RN, BSN, CDE Clinical Coordinator

The Joint Commission Advanced DSC Certification for Inpatient Diabetes Care

Diabetes Education Information for Teachers and School staff

There seem to be inconsistencies regarding diabetic management in

Causes, incidence, and risk factors

Diabetes Care 36: , 2013

DIABETIC EDUCATION MODULE ONE GENERAL OVERVIEW OF TREATMENT AND SAFETY

CLOSED LOOP MODEL FOR GLUCOSE INSULIN REGULATION SYSTEM USING LABVIEW

The Family Library. Understanding Diabetes

Glycemic Control Initiative: Insulin Order Set Changes Hypoglycemia Nursing Protocol

Type 1 Diabetes - Managing a Critical Ratio

Faculty. Program Objectives. Introducing the Problem. Diabetes is a Silent Killer. Minorities at Greater Risk of Having Type 2 Diabetes

A Simplified Approach to Initiating Insulin. 4. Not meeting glycemic goals with oral hypoglycemic agents or

Glucose Management University of Colorado Hospital

X-Plain Diabetes - Introduction Reference Summary

Transcription:

INGAR Instituto de Desarrollo y Diseño Consejo Nacional de Investigaciones Científicas y Técnicas Universidad Tecnológica Nacional Anomaly Detection in the Artificial Pancreas Luis Ávila, Ernesto Martínez INGAR (CONICET-UTN), Avellaneda 3657, Santa Fe S3002 GJC, Argentina {avilaol, ecmarti}@santafe-conicet.gob.ar 18 th September 2013 CAIS 2013-4º Congreso Argentino de Informática y Salud 18 al 20 de Septiembre de 2013 Universidad Nacional de Córdoba

Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Diabetes mellitus disease resulting from the impaired mechanism of insulin secretion from the pancreas In Type 1 Diabetes β-cells in the pancreas do not produce insulin (Insulin-dependent). In Type 2 Diabetes the cells in body do not utilize insulin properly (Insulin-independent). CAIS 2013-4º Congreso Argentino de Informática y Salud 2/16

Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Artificial pancreas A safety-critical design of the artificial pancreas should guarantee fast detection of performance degradation! CAIS 2013-4º Congreso Argentino de Informática y Salud 3/16

Diabetes mellitus Artificial pancreas Faulty conditions Reference behavior Faults and surprising events Unstable signal output, interference or poor calibration Dietary change, exercise, stress or pregnancy Changes due to constraint activation or tuning of control algorithm Obstruction of the infusion catheter or mechanical failures These drawbacks make clear the necessity for supervision of the control loop and early detection of performance degradation CAIS 2013-4º Congreso Argentino de Informática y Salud 4/16

Diabetes mellitus Artificial pancreas Faulty conditions Specified behavior Specified (optimal) behavior Detection of performance degradation in the regulation loop can be achieved by defining an optimal specified behavior and comparing it with real measurements obtained through Continuous Glucose Monitoring. Assuming an optimal control policy is used to control the glucoseinsulin dynamics over time, a reference behavior allows making a conjecture on expected BG levels. Significant deviationsfrom optimal behavior are evidence of changes in properly functioning of one or more components of the AP. CAIS 2013-4º Congreso Argentino de Informática y Salud 5/16

Patient model Error Grid Analysis Patient (stochastic) model Bergman s two-compartment model plus Ito s stochastic process to capture the patient variability using the variance parameter. ( ) + (, ) ( + )( + ) dg Gin t NHGB p3 I G p2ia p5 KM GX Gren = + dt V G ( K + G) V V G X M G G σε dt CGM sensors record values every 5 minutes Stochastic samples generated with an Ito s process CAIS 2013-4º Congreso Argentino de Informática y Salud 6/16

Bayesian surprise Error Grid Analysis Error Grid Analysis An AP should be regularly tested to assess on-line if it is performing well. Many tools have been proposed to gauge accuracy of continuous glucose sensors. Clarke: accounts for the distance of the current method to a reference and gives significance to deviations from the desired behavior. Consensus: based on the expertise of a large panel of clinicians to solve the problem of discontinuities presented by Clarke EGA. Continuous: evaluate not only sensor accuracy in terms of correct presentation of BGL but also the direction and rate of BG fluctuations. CAIS 2013-4º Congreso Argentino de Informática y Salud 7/16

Clarke s grid Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration It uses a Cartesian diagram where values estimated by the technique under scrutiny are displayed against the values provided by the reference method The diagonal line represents perfect agreement between the two readings. Points below and above the 45º line indicate over and underestimation of BG values. Region A: accuracy with respect to the reference. Region B: benign deviations. Region C: inadequate treatment. Region D: failure to detect hypo- or hyperglycemia. Region E: confusion of needed treatment. CAIS 2013-4º Congreso Argentino de Informática y Salud 8/16

Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration PID and variability Specified vs PID σ=0.10 Specified vs PID σ=0.50 CAIS 2013-4º Congreso Argentino de Informática y Salud 9/16

Closed-Loop EGA Avoiding hypoglycemia is the most important issue! Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration Through adaptation, the Consensusgrid can be used to assess an AP performance. y-axis:bgl when the loop behaves optimally. x-axis:bgl for current dynamics. Optimal control should guarantee normoglycemia, reference is limited between 70 and 180 mg/dl. CAIS 2013-4º Congreso Argentino de Informática y Salud 10/16

Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration CL-EGA: variability The modified CG-EGA assess pointand rateaccuracy Specified vs GPRL Closed loop performance for variability parameter σ=0.50. GPRL PID Specified vs PID CAIS 2013-4º Congreso Argentino de Informática y Salud 11/16

Clarke s grid PID and variability Closed-Loop EGA CL-EGA: variability CL-EGA: miscalibration CL-EGA: miscalibration Assessment of closed loop performance using calibration parameter ξ=10%. Specified vs GPRL Specified vs PID CAIS 2013-4º Congreso Argentino de Informática y Salud 12/16

Specified behavior Bayesian Surprise Specified behavior Developing an ability to rapidly detect surprising events is crucial in allowing safety critical systems to quickly identify potential risks and dangerous situations. The amount of surprise in new data from an AP by looking at the changes that take place in going from the specifiedto the current loop functioning CAIS 2013-4º Congreso Argentino de Informática y Salud 13/16

Specified behavior Bayesian Surprise Bayesian Surprise Any deviation from specified operation accounts for a surprising event in the closed-loop functioning Assessment of variability σ=0.50. GPRL PID Fuzzy. P KL Surprisedescribes pointwise differences between the optimal and the current loop operation T KL Surprisedescribes a progressive shift in the closed-loop dynamics CAIS 2013-4º Congreso Argentino de Informática y Salud 14/16

Summary Questions Summary Error Grid Analysis could be reused as a performance monitoring tool to detect glycemic variability and faulty conditions in an AP. We emphasize the importance of using well established methods in clinical practice to assess performance degradation. Our aim is to develop a generic on-line performance monitoring tool for the artificial pancreas that accounts for glycemic variability and faults using Bayesian inference. CAIS 2013-4º Congreso Argentino de Informática y Salud 15/16

Summary Questions Questions CAIS 2013-4º Congreso Argentino de Informática y Salud